Dry Eye Syndrome Treatment Market By Drug, By Dosage form, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032

The Dry Eye Syndrome Treatment Market was valued for $4,725.00 million in 2022 and is estimated to reach $9,316.50 million by 2032, exhibiting a CAGR of 7.1% from 2023 to 2032.

Dry eye disease is a common condition that occurs when a patient's tears are unable to provide adequate lubrication for their eyes. Dry eye disease (DED), also known as dry eye syndrome (DES), keratoconjunctivitis sicca (KCS), and keratitis sicca, is a multifactorial disease of the ocular surface due to a loss of homeostasis of the tear film.

The growth of the dry eye syndrome treatment market is driven by rise in geriatric population, surge in prevalence of dry eye diseases, and increase in demand for effective treatment. In the geriatric people, there is decrease in efficiency of lacrimal glands to produce tears. Thus, lack of tears production leads to dry eye condition in geriatric people. For instance, according to the report published by the America’s Health Ranking by United Health Foundation, in 2021, it has been estimated that more than 54 million adults aged 65 and older live in the U.S., which is about 16.5% of the nation’s population.

Moreover, large medical technology firms have increasingly focused on acquiring companies that provide solutions for dry eye syndrome treatments, which is expected to notably contribute toward the market growth. Prominent players in the global dry eye syndrome treatment market have adopted various strategies such as product launches, acquisitions, and investments in R&D for advancement in dry eye syndrome treatments to strengthen their position in the market and sustain the competitive environment. For instance, in January 2023, Viatris Inc., a global healthcare company, announced its complete acquisition of Oyster Point Pharma and Famy Life Sciences to establish a new Viatris Eye Care Division.

Moreover, alarming increase in prevalence of dry eye diseases (DED), technological advancements in dry eye syndrome treatment, and long-term use of contact lens are some of the key factors that drive the growth of the market. Furthermore, extensive screen time and computer-based work notably contribute toward the growth in prevalence of dry eye syndrome (DES). However, stringent regulatory process for drug approval and dearth of skilled ophthalmologists may restrain the market growth. Conversely, increased application of dry eye syndrome treatment among the geriatric population and recent drug launched in market is expected to provide lucrative opportunities for the growth of the market in the near future. In addition, extensive R&D activities in the field of dry eye syndrome treatment along with significant improvement in medical infrastructure are anticipated to open new avenues for the expansion of the market during the forecast period.

The dry eye syndrome treatment market is segmented into drug, dosage form, distribution channel, and region. On the basis of drug, the market is classified into lubricant, dry eye syndrome drugs and others. On the basis of dosage form, the market is categorized into eye drops, ointments, and others. On the basis of distribution channel, it is classified into hospital pharmacies, retail pharmacies and online providers. On the basis of region, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major companies profiled in the report include Abbvie, Viatris, Novartis AG, Bausch & Lomb Incorporated, Sun Pharma, Novaliq, Santen Pharmaceutical Co., AFT Pharmaceuticals, Alcon and Johnson & Johnson.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the dry eye syndrome treatment market analysis from 2022 to 2032 to identify the prevailing dry eye syndrome treatment market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the dry eye syndrome treatment market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global dry eye syndrome treatment market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

New Product Development/ Product Matrix of Key Players
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Criss-cross segment analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
Key player details (including location, contact details, supplier/vendor network etc. in excel format)
SWOT Analysis

Key Market Segments

By Drug

Lubricant
Dry eye syndrome drugs
Others

By Dosage form

Eye drops
Ointments
Other

By Distribution Channel

Hospital pharmacies
Retail pharmacies
Online providers

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
AbbVie Inc.
Viatris Inc.
Novartis AG
Bausch Health Companies Inc
Novaliq
AFT Pharmaceuticals Limited
Alcon
Johnson & Johnson (J&J)
Santen Pharmaceutical Co., Ltd.
Sun Pharmaceutical Industries Ltd.

Please note:

Online Access price format is valid for 60 days access. Printing is not enabled.
PDF Single and Enterprise price formats enable printing.

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
3.3. Porter’s five forces analysis
3.4. Market dynamics

CHAPTER 4: DRY EYE SYNDROME TREATMENT MARKET, BY DRUG

4.1. Overview
4.2. Lubricant
4.3. Dry eye syndrome drugs
4.4. Others

CHAPTER 5: DRY EYE SYNDROME TREATMENT MARKET, BY DOSAGE FORM

5.1. Overview
5.2. Eye drops
5.3. Ointments
5.4. Other

CHAPTER 6: DRY EYE SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL

6.1. Overview
6.2. Hospital pharmacies
6.3. Retail pharmacies
6.4. Online providers

CHAPTER 7: DRY EYE SYNDROME TREATMENT MARKET, BY REGION

7.1. Overview
7.2. North America
7.3. Europe
7.4. Asia-Pacific
7.5. LAMEA

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

9.1. AbbVie Inc.
9.2. Viatris Inc.
9.3. Novartis AG
9.4. Bausch Health Companies Inc
9.5. Sun Pharmaceutical Industries Ltd.
9.6. Novaliq
9.7. Santen Pharmaceutical Co., Ltd.
9.8. AFT Pharmaceuticals Limited
9.9. Alcon
9.10. Johnson & Johnson (J&J)

List of Tables

Table 01. Global Dry Eye Syndrome Treatment Market, by Drug, 2022-2032 ($ Million)
Table 02. Dry Eye Syndrome Treatment Market for Lubricant, by Region, 2022-2032 ($ Million)
Table 03. Dry Eye Syndrome Treatment Market for Dry Eye Syndrome Drugs, by Region, 2022-2032 ($ Million)
Table 04. Dry Eye Syndrome Treatment Market for Others, by Region, 2022-2032 ($ Million)
Table 05. Global Dry Eye Syndrome Treatment Market, by Dosage Form, 2022-2032 ($ Million)
Table 06. Dry Eye Syndrome Treatment Market for Eye Drops, by Region, 2022-2032 ($ Million)
Table 07. Dry Eye Syndrome Treatment Market for Ointments, by Region, 2022-2032 ($ Million)
Table 08. Dry Eye Syndrome Treatment Market for Other, by Region, 2022-2032 ($ Million)
Table 09. Global Dry Eye Syndrome Treatment Market, by Distribution Channel, 2022-2032 ($ Million)
Table 10. Dry Eye Syndrome Treatment Market for Hospital Pharmacies, by Region, 2022-2032 ($ Million)
Table 11. Dry Eye Syndrome Treatment Market for Retail Pharmacies, by Region, 2022-2032 ($ Million)
Table 12. Dry Eye Syndrome Treatment Market for Online Providers, by Region, 2022-2032 ($ Million)
Table 13. Dry Eye Syndrome Treatment Market, by Region, 2022-2032 ($ Million)
Table 14. North America Dry Eye Syndrome Treatment Market, by Drug, 2022-2032 ($ Million)
Table 15. North America Dry Eye Syndrome Treatment Market, by Dosage Form, 2022-2032 ($ Million)
Table 16. North America Dry Eye Syndrome Treatment Market, by Distribution Channel, 2022-2032 ($ Million)
Table 17. North America Dry Eye Syndrome Treatment Market, by Country, 2022-2032 ($ Million)
Table 18. U.S. Dry Eye Syndrome Treatment Market, by Drug, 2022-2032 ($ Million)
Table 19. U.S. Dry Eye Syndrome Treatment Market, by Dosage Form, 2022-2032 ($ Million)
Table 20. U.S. Dry Eye Syndrome Treatment Market, by Distribution Channel, 2022-2032 ($ Million)
Table 21. Canada Dry Eye Syndrome Treatment Market, by Drug, 2022-2032 ($ Million)
Table 22. Canada Dry Eye Syndrome Treatment Market, by Dosage Form, 2022-2032 ($ Million)
Table 23. Canada Dry Eye Syndrome Treatment Market, by Distribution Channel, 2022-2032 ($ Million)
Table 24. Mexico Dry Eye Syndrome Treatment Market, by Drug, 2022-2032 ($ Million)
Table 25. Mexico Dry Eye Syndrome Treatment Market, by Dosage Form, 2022-2032 ($ Million)
Table 26. Mexico Dry Eye Syndrome Treatment Market, by Distribution Channel, 2022-2032 ($ Million)
Table 27. Europe Dry Eye Syndrome Treatment Market, by Drug, 2022-2032 ($ Million)
Table 28. Europe Dry Eye Syndrome Treatment Market, by Dosage Form, 2022-2032 ($ Million)
Table 29. Europe Dry Eye Syndrome Treatment Market, by Distribution Channel, 2022-2032 ($ Million)
Table 30. Europe Dry Eye Syndrome Treatment Market, by Country, 2022-2032 ($ Million)
Table 31. Germany Dry Eye Syndrome Treatment Market, by Drug, 2022-2032 ($ Million)
Table 32. Germany Dry Eye Syndrome Treatment Market, by Dosage Form, 2022-2032 ($ Million)
Table 33. Germany Dry Eye Syndrome Treatment Market, by Distribution Channel, 2022-2032 ($ Million)
Table 34. France Dry Eye Syndrome Treatment Market, by Drug, 2022-2032 ($ Million)
Table 35. France Dry Eye Syndrome Treatment Market, by Dosage Form, 2022-2032 ($ Million)
Table 36. France Dry Eye Syndrome Treatment Market, by Distribution Channel, 2022-2032 ($ Million)
Table 37. UK Dry Eye Syndrome Treatment Market, by Drug, 2022-2032 ($ Million)
Table 38. UK Dry Eye Syndrome Treatment Market, by Dosage Form, 2022-2032 ($ Million)
Table 39. UK Dry Eye Syndrome Treatment Market, by Distribution Channel, 2022-2032 ($ Million)
Table 40. Italy Dry Eye Syndrome Treatment Market, by Drug, 2022-2032 ($ Million)
Table 41. Italy Dry Eye Syndrome Treatment Market, by Dosage Form, 2022-2032 ($ Million)
Table 42. Italy Dry Eye Syndrome Treatment Market, by Distribution Channel, 2022-2032 ($ Million)
Table 43. Spain Dry Eye Syndrome Treatment Market, by Drug, 2022-2032 ($ Million)
Table 44. Spain Dry Eye Syndrome Treatment Market, by Dosage Form, 2022-2032 ($ Million)
Table 45. Spain Dry Eye Syndrome Treatment Market, by Distribution Channel, 2022-2032 ($ Million)
Table 46. Rest of Europe Dry Eye Syndrome Treatment Market, by Drug, 2022-2032 ($ Million)
Table 47. Rest of Europe Dry Eye Syndrome Treatment Market, by Dosage Form, 2022-2032 ($ Million)
Table 48. Rest of Europe Dry Eye Syndrome Treatment Market, by Distribution Channel, 2022-2032 ($ Million)
Table 49. Asia-Pacific Dry Eye Syndrome Treatment Market, by Drug, 2022-2032 ($ Million)
Table 50. Asia-Pacific Dry Eye Syndrome Treatment Market, by Dosage Form, 2022-2032 ($ Million)
Table 51. Asia-Pacific Dry Eye Syndrome Treatment Market, by Distribution Channel, 2022-2032 ($ Million)
Table 52. Asia-Pacific Dry Eye Syndrome Treatment Market, by Country, 2022-2032 ($ Million)
Table 53. China Dry Eye Syndrome Treatment Market, by Drug, 2022-2032 ($ Million)
Table 54. China Dry Eye Syndrome Treatment Market, by Dosage Form, 2022-2032 ($ Million)
Table 55. China Dry Eye Syndrome Treatment Market, by Distribution Channel, 2022-2032 ($ Million)
Table 56. Japan Dry Eye Syndrome Treatment Market, by Drug, 2022-2032 ($ Million)
Table 57. Japan Dry Eye Syndrome Treatment Market, by Dosage Form, 2022-2032 ($ Million)
Table 58. Japan Dry Eye Syndrome Treatment Market, by Distribution Channel, 2022-2032 ($ Million)
Table 59. India Dry Eye Syndrome Treatment Market, by Drug, 2022-2032 ($ Million)
Table 60. India Dry Eye Syndrome Treatment Market, by Dosage Form, 2022-2032 ($ Million)
Table 61. India Dry Eye Syndrome Treatment Market, by Distribution Channel, 2022-2032 ($ Million)
Table 62. Australia Dry Eye Syndrome Treatment Market, by Drug, 2022-2032 ($ Million)
Table 63. Australia Dry Eye Syndrome Treatment Market, by Dosage Form, 2022-2032 ($ Million)
Table 64. Australia Dry Eye Syndrome Treatment Market, by Distribution Channel, 2022-2032 ($ Million)
Table 65. South Korea Dry Eye Syndrome Treatment Market, by Drug, 2022-2032 ($ Million)
Table 66. South Korea Dry Eye Syndrome Treatment Market, by Dosage Form, 2022-2032 ($ Million)
Table 67. South Korea Dry Eye Syndrome Treatment Market, by Distribution Channel, 2022-2032 ($ Million)
Table 68. Rest of Asia-Pacific Dry Eye Syndrome Treatment Market, by Drug, 2022-2032 ($ Million)
Table 69. Rest of Asia-Pacific Dry Eye Syndrome Treatment Market, by Dosage Form, 2022-2032 ($ Million)
Table 70. Rest of Asia-Pacific Dry Eye Syndrome Treatment Market, by Distribution Channel, 2022-2032 ($ Million)
Table 71. LAMEA Dry Eye Syndrome Treatment Market, by Drug, 2022-2032 ($ Million)
Table 72. LAMEA Dry Eye Syndrome Treatment Market, by Dosage Form, 2022-2032 ($ Million)
Table 73. LAMEA Dry Eye Syndrome Treatment Market, by Distribution Channel, 2022-2032 ($ Million)
Table 74. LAMEA Dry Eye Syndrome Treatment Market, by Country, 2022-2032 ($ Million)
Table 75. Brazil Dry Eye Syndrome Treatment Market, by Drug, 2022-2032 ($ Million)
Table 76. Brazil Dry Eye Syndrome Treatment Market, by Dosage Form, 2022-2032 ($ Million)
Table 77. Brazil Dry Eye Syndrome Treatment Market, by Distribution Channel, 2022-2032 ($ Million)
Table 78. Saudi Arabia Dry Eye Syndrome Treatment Market, by Drug, 2022-2032 ($ Million)
Table 79. Saudi Arabia Dry Eye Syndrome Treatment Market, by Dosage Form, 2022-2032 ($ Million)
Table 80. Saudi Arabia Dry Eye Syndrome Treatment Market, by Distribution Channel, 2022-2032 ($ Million)
Table 81. South Africa Dry Eye Syndrome Treatment Market, by Drug, 2022-2032 ($ Million)
Table 82. South Africa Dry Eye Syndrome Treatment Market, by Dosage Form, 2022-2032 ($ Million)
Table 83. South Africa Dry Eye Syndrome Treatment Market, by Distribution Channel, 2022-2032 ($ Million)
Table 84. Rest of LAMEA Dry Eye Syndrome Treatment Market, by Drug, 2022-2032 ($ Million)
Table 85. Rest of LAMEA Dry Eye Syndrome Treatment Market, by Dosage Form, 2022-2032 ($ Million)
Table 86. Rest of LAMEA Dry Eye Syndrome Treatment Market, by Distribution Channel, 2022-2032 ($ Million)
Table 87. Abbvie Inc.: Key Executives
Table 88. Abbvie Inc.: Company Snapshot
Table 89. Abbvie Inc.: Product Segments
Table 90. Abbvie Inc.: Product Portfolio
Table 91. Abbvie Inc.: Key Stratergies
Table 92. Viatris Inc.: Key Executives
Table 93. Viatris Inc.: Company Snapshot
Table 94. Viatris Inc.: Product Segments
Table 95. Viatris Inc.: Product Portfolio
Table 96. Viatris Inc.: Key Stratergies
Table 97. Novartis Ag: Key Executives
Table 98. Novartis Ag: Company Snapshot
Table 99. Novartis Ag: Product Segments
Table 100. Novartis Ag: Product Portfolio
Table 101. Bausch Health Companies Inc: Key Executives
Table 102. Bausch Health Companies Inc: Company Snapshot
Table 103. Bausch Health Companies Inc: Product Segments
Table 104. Bausch Health Companies Inc: Product Portfolio
Table 105. Bausch Health Companies Inc: Key Stratergies
Table 106. Sun Pharmaceutical Industries Ltd.: Key Executives
Table 107. Sun Pharmaceutical Industries Ltd.: Company Snapshot
Table 108. Sun Pharmaceutical Industries Ltd.: Product Segments
Table 109. Sun Pharmaceutical Industries Ltd.: Product Portfolio
Table 110. Sun Pharmaceutical Industries Ltd.: Key Stratergies
Table 111. Novaliq: Key Executives
Table 112. Novaliq: Company Snapshot
Table 113. Novaliq: Product Segments
Table 114. Novaliq: Product Portfolio
Table 115. Novaliq: Key Stratergies
Table 116. Santen Pharmaceutical Co. Ltd.: Key Executives
Table 117. Santen Pharmaceutical Co. Ltd.: Company Snapshot
Table 118. Santen Pharmaceutical Co. Ltd.: Product Segments
Table 119. Santen Pharmaceutical Co. Ltd.: Product Portfolio
Table 120. Santen Pharmaceutical Co. Ltd.: Key Stratergies
Table 121. Aft Pharmaceuticals Limited: Key Executives
Table 122. Aft Pharmaceuticals Limited: Company Snapshot
Table 123. Aft Pharmaceuticals Limited: Product Segments
Table 124. Aft Pharmaceuticals Limited: Product Portfolio
Table 125. Alcon: Key Executives
Table 126. Alcon: Company Snapshot
Table 127. Alcon: Product Segments
Table 128. Alcon: Product Portfolio
Table 129. Johnson & Johnson (J&J): Key Executives
Table 130. Johnson & Johnson (J&J): Company Snapshot
Table 131. Johnson & Johnson (J&J): Product Segments
Table 132. Johnson & Johnson (J&J): Product Portfolio

List of Figures

Figure 01. Dry Eye Syndrome Treatment Market, 2022-2032
Figure 02. Segmentation of Dry Eye Syndrome Treatment Market, 2022-2032
Figure 03. Top Investment Pockets in Dry Eye Syndrome Treatment Market (2023-2032)
Figure 04. Moderate Bargaining Power of Suppliers
Figure 05. Moderate Threat of New Entrants
Figure 06. Moderate Threat of Substitutes
Figure 07. Moderate Intensity of Rivalry
Figure 08. Moderate Bargaining Power of Buyers
Figure 09. Global Dry Eye Syndrome Treatment Market: Drivers, Restraints and Opportunities
Figure 10. Dry Eye Syndrome Treatment Market, by Drug, 2022 and 2032 (%)
Figure 11. Comparative Share Analysis of Dry Eye Syndrome Treatment Market for Lubricant, by Country 2022 and 2032 (%)
Figure 12. Comparative Share Analysis of Dry Eye Syndrome Treatment Market for Dry Eye Syndrome Drugs, by Country 2022 and 2032 (%)
Figure 13. Comparative Share Analysis of Dry Eye Syndrome Treatment Market for Others, by Country 2022 and 2032 (%)
Figure 14. Dry Eye Syndrome Treatment Market, by Dosage Form, 2022 and 2032 (%)
Figure 15. Comparative Share Analysis of Dry Eye Syndrome Treatment Market for Eye Drops, by Country 2022 and 2032 (%)
Figure 16. Comparative Share Analysis of Dry Eye Syndrome Treatment Market for Ointments, by Country 2022 and 2032 (%)
Figure 17. Comparative Share Analysis of Dry Eye Syndrome Treatment Market for Other, by Country 2022 and 2032 (%)
Figure 18. Dry Eye Syndrome Treatment Market, by Distribution Channel, 2022 and 2032 (%)
Figure 19. Comparative Share Analysis of Dry Eye Syndrome Treatment Market for Hospital Pharmacies, by Country 2022 and 2032 (%)
Figure 20. Comparative Share Analysis of Dry Eye Syndrome Treatment Market for Retail Pharmacies, by Country 2022 and 2032 (%)
Figure 21. Comparative Share Analysis of Dry Eye Syndrome Treatment Market for Online Providers, by Country 2022 and 2032 (%)
Figure 22. Dry Eye Syndrome Treatment Market by Region, 2022 and 2032 (%)
Figure 23. U.S. Dry Eye Syndrome Treatment Market, 2022-2032 ($ Million)
Figure 24. Canada Dry Eye Syndrome Treatment Market, 2022-2032 ($ Million)
Figure 25. Mexico Dry Eye Syndrome Treatment Market, 2022-2032 ($ Million)
Figure 26. Germany Dry Eye Syndrome Treatment Market, 2022-2032 ($ Million)
Figure 27. France Dry Eye Syndrome Treatment Market, 2022-2032 ($ Million)
Figure 28. UK Dry Eye Syndrome Treatment Market, 2022-2032 ($ Million)
Figure 29. Italy Dry Eye Syndrome Treatment Market, 2022-2032 ($ Million)
Figure 30. Spain Dry Eye Syndrome Treatment Market, 2022-2032 ($ Million)
Figure 31. Rest of Europe Dry Eye Syndrome Treatment Market, 2022-2032 ($ Million)
Figure 32. China Dry Eye Syndrome Treatment Market, 2022-2032 ($ Million)
Figure 33. Japan Dry Eye Syndrome Treatment Market, 2022-2032 ($ Million)
Figure 34. India Dry Eye Syndrome Treatment Market, 2022-2032 ($ Million)
Figure 35. Australia Dry Eye Syndrome Treatment Market, 2022-2032 ($ Million)
Figure 36. South Korea Dry Eye Syndrome Treatment Market, 2022-2032 ($ Million)
Figure 37. Rest of Asia-Pacific Dry Eye Syndrome Treatment Market, 2022-2032 ($ Million)
Figure 38. Brazil Dry Eye Syndrome Treatment Market, 2022-2032 ($ Million)
Figure 39. Saudi Arabia Dry Eye Syndrome Treatment Market, 2022-2032 ($ Million)
Figure 40. South Africa Dry Eye Syndrome Treatment Market, 2022-2032 ($ Million)
Figure 41. Rest of LAMEA Dry Eye Syndrome Treatment Market, 2022-2032 ($ Million)
Figure 42. Top Winning Strategies, by Year (2020-2023)
Figure 43. Top Winning Strategies, by Development (2020-2023)
Figure 44. Top Winning Strategies, by Company (2020-2023)
Figure 45. Product Mapping of Top 10 Players
Figure 46. Competitive Dashboard
Figure 47. Competitive Heatmap: Dry Eye Syndrome Treatment Market
Figure 48. Top Player Positioning, 2022
Figure 49. Abbvie Inc.: Net Revenue, 2020-2022 ($ Million)
Figure 50. Abbvie Inc.: Revenue Share by Segment, 2022 (%)
Figure 51. Abbvie Inc.: Revenue Share by Region, 2022 (%)
Figure 52. Viatris Inc.: Net Sales, 2020-2022 ($ Million)
Figure 53. Viatris Inc.: Revenue Share by Segment, 2022 (%)
Figure 54. Novartis Ag: Net Sales, 2020-2022 ($ Million)
Figure 55. Novartis Ag: Revenue Share by Segment, 2022 (%)
Figure 56. Novartis Ag: Revenue Share by Region, 2022 (%)
Figure 57. Bausch Health Companies Inc: Net Revenue, 2020-2022 ($ Million)
Figure 58. Bausch Health Companies Inc: Revenue Share by Segment, 2022 (%)
Figure 59. Sun Pharmaceutical Industries Ltd.: Net Revenue, 2020-2022 ($ Million)
Figure 60. Sun Pharmaceutical Industries Ltd.: Revenue Share by Region, 2021 (%)
Figure 61. Santen Pharmaceutical Co. Ltd.: Net Revenue, 2019-2021 ($ Million)
Figure 62. Aft Pharmaceuticals Limited: Net Revenue, 2020-2022 ($ Million)
Figure 63. Aft Pharmaceuticals Limited: Revenue Share by Region, 2022 (%)
Figure 64. Alcon: Net Sales, 2020-2022 ($ Million)
Figure 65. Alcon: Revenue Share by Segment, 2022 (%)
Figure 66. Alcon: Revenue Share by Region, 2022 (%)
Figure 67. Johnson & Johnson (J&J): Research & Development Expenditure, 2020-2021 ($Billion)
Figure 68. Johnson & Johnson (J&J): Net Revenue, 2020-2022 ($Billion)
Figure 69. Johnson & Johnson (J&J): Revenue Share by Region, 2022 (%)
Figure 70. Johnson & Johnson (J&J): Revenue Share by Segment, 2022 (%)

Executive Summary

According to the report, the dry eye syndrome treatment market was valued at $4.7 billion in 2022, and is estimated to reach $9.3 billion by 2032, growing at a CAGR of 7.1% from 2023 to 2032.

Dry eye syndrome occurs due to inappropriate formation of tears evaporating too quickly or a dearth of tears to lubricate and nourish the eye. If left untreated, this condition can lead to pain, ulcers, scars on the cornea, and even loss of vision. For the treatment of dry eyes the lubricating solutions and ointments are used.

The key market trends driving the growth of the Dry eye syndrome treatment market include rise in demand for Dry eye syndrome treatment for treatment, improvements in healthcare infrastructure, and investments in R&D activities by key market players for the development of advanced dry eye products. In addition, rise in the prevalence of eye-related problems such as dry eyes and vision impairments contributes to the growth of the market. Thus, high prevalence of eye related disease along with growing demand of Dry eye syndrome treatments is expected to drive the Dry eye syndrome treatment market during the forecast period.

Furthermore, acquisition, new product approval and product launch in market drives the growth of market For instance, in January 2023, Viatris Inc., a global healthcare company, announced its complete acquisition of Oyster Point Pharma and Famy Life Sciences to establish a new Viatris Eye Care Division. In addition, a rise in awareness about the effectiveness of Dry eye syndrome treatment, surge in incidence of dry eye syndrome, increase in availability & affordability of healthcare treatment and rise in number of hospital admissions contributes to the growth of market.

The global dry eye syndrome treatment market is driven by rise in prevalence of dry eye syndrome, increase in geriatric population, growth in awareness about the diagnosis and treatment of the disease, and increase in use of contact lenses. However, stringent regulatory process for drug approval and dearth of skilled ophthalmologists restrain the market growth. Conversely, increased adoption of Dry eye syndrome treatment among the population is expected to provide lucrative opportunities for the growth of the market. On the contrary, rise in research and development activities by key market players and increase in healthcare expenditure has further encouraged many key players to enter emerging markets, thus offering lucrative opportunities for the expansion of the Dry eye syndrome treatment market.

Moreover, alarming increase in prevalence of dry eye diseases (DED), technological advancements in dry eye syndrome treatment, and long-term use of contact lens are some of the key factors that drive the growth of the market. Furthermore, extensive screen time and computer-based work notably contribute toward the growth in prevalence of dry eye syndrome (DES)
The market also offers growth opportunities to the key players in the market. The target population is in tremendous need of cost-effective services in regions like Europe and Asia-Pacific. Hence, challenges to cater the unmet needs of the target population provide growth opportunities. Online medical services have gained high traction in the last 4 years. As a result, engaged stakeholders in the industry have partnered with existing delivery services organizations.

The dry eye syndrome treatment market is segmented into drug, dosage form, distribution channel, and region. On the basis of drug, the market is classified into lubricant, dry eye syndrome drugs others. On the basis of dosage form, the market is categorized into eye drops, ointments, and others. On the basis of distribution channel, it is classified into hospital pharmacies, retail pharmacies and online providers. On the basis of region, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

The key players profiled in the Abbvie, Viatris, Novartis AG, Bausch & Lomb Incorporated, Sun Pharma, Novaliq, Santen Pharmaceutical Co., AFT Pharmaceuticals, Alcon and Johnson & Johnson. The players in the market have been actively engaged in the adoption of various strategies such as acquisition, product launch, and partnership to remain competitive and gain an advantage over the competitors in the market.

Key Market Insights (Updated)

On the basis of Drug, the dry eye syndrome drugs segment was the major share contributor in 2022.

By dosage form, the eye drops segment dominated the market in 2022, and the ointments segment is expected to grow at the fastest CAGR during the forecast period.

On the basis of distribution channel, the retail pharmacies segment is anticipated to grow with the highest CAGR throughout the forecast period.

Region wise, North America garnered the largest revenue share in 2022, however, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Companies Mentioned

AbbVie Inc.
Viatris Inc.
Novartis AG
Bausch Health Companies Inc
Novaliq
AFT Pharmaceuticals Limited
Alcon
Johnson & Johnson (J&J)
Santen Pharmaceutical Co., Ltd.
Sun Pharmaceutical Industries Ltd.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic news articles and other related releases for market evaluation
Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

LOADING...

License	Format	Properties	Price
SINGLE USER LICENSE Online Access		This is a single user license, allowing one user access to the product.	€3519EUR$3,570USD£2,910GBP
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4801EUR$4,871USD£3,970GBP €5648EUR$5,730USD£4,670GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€7571EUR$7,680USD£6,260GBP €9463EUR$9,600USD£7,825GBP

Key Benefits For Stakeholders

Additional benefits you will get with this purchase are:

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Key Market Segments

By Drug

By Dosage form

By Distribution Channel

By Region

Table of Contents

Executive Summary

Key Market Insights (Updated)

Companies Mentioned

Methodology

Related Topics

Related Reports

Dry Eye Syndrome Treatment Market Size, Share & Trends Analysis Report By Type, By Drug, By Product, By Dosage Form, By Sales Channel, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

Dry Eye Syndrome Market Report by Disease Type, Drug Type, Product, Distribution Channel, and Region 2024-2032

Dry Eye Syndrome Market by Drug, Product - Global Forecast 2025-2030

Dry Eye Medication Market by Drug Type, Dosage Form, End-User, Distribution Channel - Global Forecast 2025-2030

Dry Eye Syndrome Drugs Market 2024-2028